| Field | Specification |
|---|---|
| Gene ID | |
| UniProt # | |
| Host | |
| Clone | |
| Clonality | |
| Isotype | |
| Applications | |
| Conjugate | |
| Concentration | |
| Storage | |
| Storage buffer | |
| Shipping | |
| Catalog no. (Mfr.) | |
| Main SKU |
Product Overview
CD11c is a 150 kD glycoprotein also known as αX integrin, CR4, and p150. CD11c forms a αXβ2 heterodimer with β2 integrin (CD18). It is primarily expressed on dendritic cells, NK cells, a subset of intestinal intraepithelial lymphocytes (IEL), and some activated T cells. The αXβ2 integrin plays an important role in cell-cell contact by binding its ligands: iC3b, fibrinogen and CD54.
Validated Applications & Recommended Dilutions
| Application | Recommended Dilution |
|---|---|
| Flow Cytometry | See product datasheet |
Antibody Specifications
| Target | CD11c |
|---|---|
| Host Species | Armenian Hamster |
| Clonality | Monoclonal |
| Isotype | Armenian Hamster IgG |
| Conjugate | APC |
| Clone Number | N418 |
| Purification | See datasheet |
| Concentration | 5 μL/Test |
Immunogen
Recombinant protein fragment; see full datasheet. UniProt: Q9QXH4.
Species Reactivity & Cross-Reactivity
Validated for: Mouse. Verify suitability in your sample type prior to use. For species or applications not listed in the datasheet, consult our technical team before purchase.
Storage & Handling
This product can be stored at 2-8°C for 12 months. Please protected from prolonged exposure to light and do not freeze.
Storage Buffer: Phosphate buffered solution, pH 7.2, containing 0.09% stabilizer and 1% protein protectant.
Related Products
Browse additional antibodies targeting CD11c and complementary reagents — including secondary antibodies, blocking buffers, and detection kits — available through BioHippo.
This antibody is validated for flow cytometry applications. For intracellular targets, fix and permeabilize cells using a validated fixation/permeabilization kit (e.g., BD Cytofix/Cytoperm or similar) before staining. For surface markers, stain live or fixed cells without permeabilization. Always include a matched isotype control (Armenian Hamster IgG, Armenian Hamster origin) at the same protein concentration as the test antibody to establish non-specific binding thresholds. Recommended starting dilution/concentration: see datasheet.
This antibody has been experimentally validated in: Mouse. Cross-reactivity with other species has not been systematically evaluated. If your sample species is not listed, assess immunogen sequence homology to your target species ortholog. The immunogen used is: "" — higher sequence identity between species increases the probability of cross-reactivity, but experimental validation with appropriate controls is necessary before drawing scientific conclusions.
This product can be stored at 2-8°C for 12 months. Please protected from prolonged exposure to light and do not freeze. Storage Buffer: Phosphate buffered solution, pH 7.2, containing 0.09% stabilizer and 1% protein protectant.. To maintain antibody activity, avoid repeated freeze-thaw cycles. Aliquot into single-use volumes before first freeze. If working with the antibody frequently, keep a working stock at 4°C for up to 4 weeks — add 0.02% sodium azide to the working stock as a bacteriostatic agent if azide is not already present in the buffer. Monitor performance against a validated positive control when transitioning between storage aliquots or lots.
This monoclonal antibody (clone N418) provides highly consistent, epitope-specific recognition of CD11c, making it ideal for quantitative assays, multiplex panels, and studies requiring strict reproducibility across experiments and independent laboratories. Unlike polyclonal preparations, each production batch from a single hybridoma clone generates antibody with identical epitope specificity, affinity, and isotype — ensuring reliable signal comparison in longitudinal studies or multi-site collaborations. When citing this antibody in publications, include the clone designation (clone N418) to enable third-party reproducibility verification.
Customization & Add-ons: Can't find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
An In Situ Self-Responsive Nano-Prodrug to Enable Tumor Chemo-Metalloimmunotherapy (2025) ADVANCED FUNCTIONAL MATERIALS. 10.1002/adfm.202523215
Ultrathin Oleanolic Acid/Perfluorocarbon-Ferrocene Nanosheets Trigger Reactive Species Storm to Reshape Tumor Microenvironment for Enhanced Chemodynamic Therapy (2026) ACS Nano. 10.1021/acsnano.5c20827
Photosynthetic Plant-Derived Nanovesicles Precisely Amplify Photodynamic Effect by Light-Activated Oxygen Generation for Enhanced Cancer Photoimmunotherapy (2025) ACS Nano. 10.1021/acsnano.5c13350
Remodeling the Tumor Microenvironment: An Emerging Paradigm for Reinvigorating Immunologically Cold Tumors and Advancing Cancer Immunotherapy (2025) ACS Nano. 10.1021/acsnano.5c14644
Regulating the Tumor Microbiome through Near-Infrared-III Light-Excited Photosynthesis (2025) ACS Nano. 10.1021/acsnano.4c18954
Arsenic trioxide-based nanoparticles for enhance chemotherapy by activating pyroptosis (2025) Acta Pharmaceutica Sinica B. 10.1016/j.apsb.2025.08.003
Mitigating Doxorubicin-Induced Cardiotoxicity and Enhancing Anti-Tumor Efficacy with a Metformin-Integrated Self-Assembled Nanomedicine (2025) Advanced Science. 10.1002/advs.202415227
CRISPR/Cas9-Based Vanadium MXene-Free Radical Spatiotemporally Controlled Nanoreactor for Photothermal-Induced Multi-Effect Synergistic Antitumor Therapy (2026) Advanced Science. 10.1002/advs.202522535
Well-defined electronic configuration cyano-bridged bimetallic nanozyme for cancer catalytic-immunotherapy (2025) BIOMATERIALS. 10.1016/j.biomaterials.2025.123868
Optically controllable nanoregulators enable tumor-specific pro-ferroptosis lipometabolic reprogramming for in-situ adjuvant-free vaccination (2025) BIOMATERIALS. 10.1016/j.biomaterials.2025.123096
Radiation-triggerable bioreactors enable bioenergetic reprograming of cancer stem cell plasticity via targeted arginine metabolism disruption for augmented radio-immunotherapy (2025) BIOMATERIALS. 10.1016/j.biomaterials.2025.123391
Arginine-assembly as NO nano-donor prevents the negative feedback of macrophage repolarization by mitochondrial dysfunction for cancer immunotherapy (2024) BIOMATERIALS. 10.1016/j.biomaterials.2024.122474
Inducing ferroptosis and reversing immune evasion for the suppression of melanoma lung metastasis via neferine-loaded controlled-release system (2026) JOURNAL OF CONTROLLED RELEASE. 10.1016/j.jconrel.2026.114768
Lactiplantibacillus plantarum -derived extracellular vesicles alleviate acute lung injury by inhibiting ferroptosis of macrophages (2025) JOURNAL OF NANOBIOTECHNOLOGY. 10.1186/s12951-025-03405-y
A Trojan Horse Delivery Vehicle Carrying siRNA Nanotherapeutics with Multiple Tumor Microenvironment Responsiveness Elicits Robust Antitumor Immune Responses In Situ via a “Self-Synergistic” Approach (2023) Advanced Healthcare Materials. 10.1002/adhm.202301401
Multifunctional self-cascade nanoplatform for efficient immunotherapy through synergizing pyroptosis and self-augmented activation of cGAS-STING pathway (2025) JOURNAL OF COLLOID AND INTERFACE SCIENCE. 10.1016/j.jcis.2025.139423
Facile integration of a binary nano-prodrug with αPD-L1 as a translatable technology for potent immunotherapy of TNBC (2025) Acta Biomaterialia. 10.1016/j.actbio.2025.01.038
Spatially Confined Photoacoustic Effects of Responsive Nanoassembly Boosts Lysosomal Membrane Permeabilization and Immunotherapy of Triple-Negative Breast Cancer (2024) Acta Biomaterialia. 10.1016/j.actbio.2024.08.021
Mechanotransduction in response to ECM stiffening impairs cGAS immune signaling in tumor cells (2023) Cell Reports. 10.1016/j.celrep.2023.113213
Probiotic fermentation of Polygonatum plant polysaccharides converting fructans to glucans with enhanced anti-obesity activity (2025) INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES. 10.1016/j.ijbiomac.2025.145871
Synergistic reprogramming of the tumor immune microenvironment by Senecavirus A and STING agonist (2026) ONCOGENE. 10.1038/s41388-026-03685-0
A KIF20A-based thermosensitive hydrogel vaccine effectively potentiates immune checkpoint blockade therapy for hepatocellular carcinoma (2025) npj Vaccines. 10.1038/s41541-024-01060-2
A biomimetic solution, albumin–doxorubicin molecular complex, targeting tumor and tumor-draining lymph nodes (2024) Journal of Materials Chemistry B. 10.1039/D4TB01917B
Sequential pH/GSH-responsive stealth nanoparticles for co-delivery of anti-PD-1 antibody and paclitaxel to enhance chemoimmunotherapy of lung cancer (2025) EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. 10.1016/j.ejmech.2025.117273
Intranasal B5 promotes mucosal defence against Actinobacillus pleuropneumoniae via ameliorating early immunosuppression (2024) Virulence. 10.1080/21505594.2024.2316459
